A detailed history of Grove Bank & Trust transactions in Haleon PLC stock. As of the latest transaction made, Grove Bank & Trust holds 2,700 shares of HLN stock, worth $24,570. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,700
Previous 2,700 -0.0%
Holding current value
$24,570
Previous $22,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$8.02 - $8.67 $2,486 - $2,687
-310 Reduced 10.3%
2,700 $22,000
Q4 2023

Jan 30, 2024

SELL
$7.78 - $8.62 $1,361 - $1,508
-175 Reduced 5.49%
3,010 $24,000
Q2 2023

Jul 27, 2023

SELL
$8.04 - $9.0 $2,701 - $3,024
-336 Reduced 9.54%
3,185 $26,000
Q1 2023

May 10, 2023

SELL
$7.57 - $8.37 $9,689 - $10,713
-1,280 Reduced 26.66%
3,521 $28,000
Q4 2022

Feb 03, 2023

BUY
$6.08 - $8.06 $29,190 - $38,696
4,801 New
4,801 $38,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $42B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Grove Bank & Trust Portfolio

Follow Grove Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grove Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Grove Bank & Trust with notifications on news.